HC Wainwright Boosts Travere Therapeutics (NASDAQ:TVTX) Price Target to $19.00

Travere Therapeutics (NASDAQ:TVTX – Get Free Report) had its price target lifted by HC Wainwright from $17.00 to $19.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s target price indicates a potential upside of 248.62% from the company’s […]

Related Keywords

Arizona ,United States ,Texas ,Piper Sandler ,Peter Heerma ,Christopherr Cline ,Rice Hall James Associates ,Wells Fargo Company ,Mirae Asset Global Investments Co ,Nasdaq ,Travere Therapeutics Company Profile ,Travere Therapeutics Inc ,Securities Exchange Commission ,Travere Therapeutics ,Get Free Report ,Therapeutics Stock Down ,Exchange Commission ,Retirement System ,State Retirement System ,Asset Global Investments ,Rice Hall James ,Hall James ,Iga Nephropathy ,Travere Therapeutics Daily ,Nasdaq Tvtx ,Tvtx ,Medical ,Boost Price Target ,Hc Wainwright ,